Vikas Sinha Insider Trading $ALXN ALEXION PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Vikas Sinha.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Vikas Sinha. Vikas Sinha is CFO in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP & CFO in ALEXION PHARMACEUTICALS INC ($ALXN) and Sr VP and CFO in ALEXION PHARMACEUTICALS INC ($ALXN) and Sr. VP & CFO in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP & CFO in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP & Chief Financial Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP, CFO in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in Verona Pharma plc ($VRNA) and See Remarks in Allovir, Inc. ($ALVR).
Vikas Sinha in ALEXION PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Vikas Sinha: EVP & CFO, SVP, CFO, Sr. VP & CFO, Sr VP and CFO, SVP & CFO, SVP & Chief Financial Officer
Holdings: 178,463 shares
Current Value: $22,793,294
Latest Transaction: Aug 10 2016
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Vikas Sinha in ALEXION PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXN, ALVR, VRNA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 137.14 | 277 | 37,988 | 178,463 | 178.7 K to 178.5 K (-0.15 %) |
| Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | A | 140.16 | 31,000 | 4,344,960 | 31,000 | |
| Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 141.23 | 2 | 282 | 178,740 | 178.7 K to 178.7 K (0.00 %) |
| Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 138.91 | 1,120 | 155,579 | 178,742 | 179.9 K to 178.7 K (-0.62 %) |
| Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Grant | A | 0.00 | 8,000 | 0 | 179,862 | 171.9 K to 179.9 K (+4.65 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 138.02 | 3,487 | 481,276 | 171,862 | 175.3 K to 171.9 K (-1.99 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 139.23 | 116 | 16,151 | 175,349 | 175.5 K to 175.3 K (-0.07 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 132.02 | 287 | 37,890 | 175,465 | 175.8 K to 175.5 K (-0.16 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 141.79 | 419 | 59,410 | 175,752 | 176.2 K to 175.8 K (-0.24 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 142.25 | 435 | 61,879 | 176,171 | 176.6 K to 176.2 K (-0.25 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 143.51 | 200 | 28,702 | 176,606 | 176.8 K to 176.6 K (-0.11 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 144.36 | 500 | 72,180 | 176,806 | 177.3 K to 176.8 K (-0.28 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 145.37 | 300 | 43,611 | 177,306 | 177.6 K to 177.3 K (-0.17 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 146.22 | 100 | 14,622 | 177,606 | 177.7 K to 177.6 K (-0.06 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Grant | A | 0.00 | 11,763 | 0 | 177,706 | 165.9 K to 177.7 K (+7.09 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 145.40 | 11 | 1,599 | 165,943 | 166 K to 165.9 K (-0.01 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 143.81 | 692 | 99,517 | 165,954 | 166.6 K to 166 K (-0.42 %) |
| Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 196.52 | 675 | 132,651 | 166,646 | 167.3 K to 166.6 K (-0.40 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | A | 180.37 | 24,400 | 4,401,028 | 24,400 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 180.34 | 487 | 87,826 | 167,321 | 167.8 K to 167.3 K (-0.29 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Grant | A | 0.00 | 5,100 | 0 | 167,808 | 162.7 K to 167.8 K (+3.13 %) |
| Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 171.15 | 1,985 | 339,733 | 162,708 | 164.7 K to 162.7 K (-1.21 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 175.09 | 2 | 350 | 164,693 | 164.7 K to 164.7 K (0.00 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 174.18 | 2,701 | 470,460 | 164,695 | 167.4 K to 164.7 K (-1.61 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Grant | A | 0.00 | 11,690 | 0 | 167,396 | 155.7 K to 167.4 K (+7.51 %) |
| Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 174.37 | 676 | 117,874 | 155,706 | 156.4 K to 155.7 K (-0.43 %) |
| Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 174.06 | 895 | 155,784 | 156,382 | 157.3 K to 156.4 K (-0.57 %) |
| Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 182.08 | 5,493 | 1,000,165 | 157,277 | 162.8 K to 157.3 K (-3.37 %) |
| Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 20.90 | 20,000 | 418,000 | 100,000 | |
| Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.98 | 30,000 | 539,400 | 1,832 | |
| Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.98 | 25,000 | 449,500 | 31,832 | |
| Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 202.76 | 200 | 40,552 | 162,770 | 163 K to 162.8 K (-0.12 %) |
| Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 201.79 | 11,358 | 2,291,931 | 162,970 | 174.3 K to 163 K (-6.52 %) |
| Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 200.82 | 5,782 | 1,161,141 | 174,328 | 180.1 K to 174.3 K (-3.21 %) |
| Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 199.53 | 3,447 | 687,780 | 180,110 | 183.6 K to 180.1 K (-1.88 %) |
| Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 198.28 | 3,468 | 687,635 | 183,557 | 187 K to 183.6 K (-1.85 %) |
| Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 197.45 | 3,438 | 678,833 | 187,025 | 190.5 K to 187 K (-1.81 %) |
| Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 196.46 | 9,037 | 1,775,409 | 190,463 | 199.5 K to 190.5 K (-4.53 %) |
| Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 195.55 | 13,270 | 2,594,949 | 199,500 | 212.8 K to 199.5 K (-6.24 %) |
| Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 20.90 | 20,000 | 418,000 | 212,770 | 192.8 K to 212.8 K (+10.38 %) |
| Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.98 | 30,000 | 539,400 | 192,770 | 162.8 K to 192.8 K (+18.43 %) |
| Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 200.16 | 25,000 | 5,004,000 | 162,770 | 187.8 K to 162.8 K (-13.31 %) |
| Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.98 | 25,000 | 449,500 | 187,770 | 162.8 K to 187.8 K (+15.36 %) |
| Nov 10 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.98 | 5,693 | 102,360 | 56,832 | |
| Nov 10 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 195.00 | 5,693 | 1,110,135 | 162,770 | 168.5 K to 162.8 K (-3.38 %) |
| Nov 10 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.98 | 5,693 | 102,360 | 168,463 | 162.8 K to 168.5 K (+3.50 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.98 | 30,000 | 539,400 | 62,525 | |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.98 | 17,475 | 314,201 | 92,525 | |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.65 | 1,832 | 32,335 | 0 | |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 193.36 | 1,089 | 210,569 | 162,770 | 163.9 K to 162.8 K (-0.66 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 192.60 | 1,400 | 269,640 | 163,859 | 165.3 K to 163.9 K (-0.85 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 191.40 | 8,231 | 1,575,413 | 165,259 | 173.5 K to 165.3 K (-4.74 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 190.56 | 19,280 | 3,673,997 | 173,490 | 192.8 K to 173.5 K (-10.00 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.96 | 30,000 | 538,800 | 192,770 | 162.8 K to 192.8 K (+18.43 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 195.18 | 19,307 | 3,768,340 | 162,770 | 182.1 K to 162.8 K (-10.60 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.96 | 17,475 | 313,851 | 182,077 | 164.6 K to 182.1 K (+10.62 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.65 | 1,832 | 32,335 | 164,602 | 162.8 K to 164.6 K (+1.13 %) |
| Aug 05 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 157.82 | 1,525 | 240,676 | 162,770 | 164.3 K to 162.8 K (-0.93 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | A | 176.80 | 49,200 | 8,698,560 | 49,200 | |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Grant | A | 0.00 | 4,000 | 0 | 164,295 | 160.3 K to 164.3 K (+2.50 %) |
| Feb 10 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 157.47 | 20 | 3,149 | 137,900 | 137.9 K to 137.9 K (-0.01 %) |
| Feb 10 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 155.55 | 1,600 | 248,880 | 137,920 | 139.5 K to 137.9 K (-1.15 %) |
| Feb 10 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Grant | A | 0.00 | 9,745 | 0 | 139,520 | 129.8 K to 139.5 K (+7.51 %) |
| Feb 05 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 153.63 | 2,700 | 414,801 | 129,775 | 132.5 K to 129.8 K (-2.04 %) |
| Feb 05 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 157.14 | 852 | 133,883 | 132,475 | 133.3 K to 132.5 K (-0.64 %) |
| Jan 31 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 133.37 | 94 | 12,537 | 133,327 | 133.4 K to 133.3 K (-0.07 %) |
| Jan 31 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 133.44 | 900 | 120,096 | 133,421 | 134.3 K to 133.4 K (-0.67 %) |
| Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.65 | 32,026 | 565,259 | 1,832 | |
| Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 127.81 | 32,026 | 4,093,243 | 134,321 | 166.3 K to 134.3 K (-19.25 %) |
| Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.65 | 32,026 | 565,259 | 166,347 | 134.3 K to 166.3 K (+23.84 %) |
| Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.65 | 17,974 | 317,241 | 33,858 | |
| Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 127.66 | 17,974 | 2,294,561 | 134,321 | 152.3 K to 134.3 K (-11.80 %) |
| Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.65 | 17,974 | 317,241 | 152,295 | 134.3 K to 152.3 K (+13.38 %) |
| Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.65 | 50,000 | 882,500 | 51,832 | |
| Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 123.85 | 7,862 | 973,709 | 310,808 | 318.7 K to 310.8 K (-2.47 %) |
| Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 122.80 | 42,138 | 5,174,546 | 318,670 | 360.8 K to 318.7 K (-11.68 %) |
| Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.65 | 50,000 | 882,500 | 360,808 | 310.8 K to 360.8 K (+16.09 %) |
| Aug 07 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 116.87 | 852 | 99,573 | 310,808 | 311.7 K to 310.8 K (-0.27 %) |
| Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 110.86 | 995 | 110,306 | 311,660 | 312.7 K to 311.7 K (-0.32 %) |
| Jul 16 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.65 | 12,504 | 220,696 | 101,832 | |
| Jul 16 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 11.92 | 37,496 | 446,952 | 0 | |
| Jul 16 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 120.00 | 50,000 | 6,000,000 | 312,655 | 362.7 K to 312.7 K (-13.79 %) |
| Jul 16 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.65 | 12,504 | 220,696 | 362,655 | 350.2 K to 362.7 K (+3.57 %) |
| Jul 16 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 11.92 | 37,496 | 446,952 | 350,151 | 312.7 K to 350.2 K (+11.99 %) |
| Feb 08 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | A | 93.83 | 60,800 | 5,704,864 | 60,800 | |
| Feb 08 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Grant | A | 0.00 | 4,500 | 0 | 312,655 | 308.2 K to 312.7 K (+1.46 %) |
| Feb 06 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 96.54 | 70 | 6,758 | 308,155 | 308.2 K to 308.2 K (-0.02 %) |
| Feb 06 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 96.17 | 1,102 | 105,979 | 308,225 | 309.3 K to 308.2 K (-0.36 %) |
| Feb 06 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 95.61 | 2,311 | 220,955 | 309,327 | 311.6 K to 309.3 K (-0.74 %) |
| Jan 30 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 94.32 | 975 | 91,962 | 311,638 | 312.6 K to 311.6 K (-0.31 %) |
| Jan 30 2013 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 94.50 | 1,007 | 95,162 | 312,613 | 313.6 K to 312.6 K (-0.32 %) |
| Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | M | 11.92 | 30,000 | 357,600 | 37,496 | |
| Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 104.94 | 900 | 94,446 | 313,620 | 314.5 K to 313.6 K (-0.29 %) |
| Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 106.14 | 868 | 92,130 | 314,520 | 315.4 K to 314.5 K (-0.28 %) |
| Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 109.37 | 17,891 | 1,956,739 | 315,388 | 333.3 K to 315.4 K (-5.37 %) |
| Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 108.39 | 12,109 | 1,312,495 | 333,279 | 345.4 K to 333.3 K (-3.51 %) |
| Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 11.92 | 30,000 | 357,600 | 345,388 | 315.4 K to 345.4 K (+9.51 %) |
| Apr 30 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 89.90 | 1,667 | 149,863 | 315,388 | 317.1 K to 315.4 K (-0.53 %) |
| Apr 30 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 89.98 | 46,333 | 4,169,043 | 317,055 | 363.4 K to 317.1 K (-12.75 %) |
| Mar 22 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | M | 10.29 | 21,996 | 226,339 | 0 | |
| Mar 22 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 89.93 | 21,996 | 1,978,100 | 363,388 | 385.4 K to 363.4 K (-5.71 %) |
| Mar 22 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 10.29 | 21,996 | 226,339 | 385,384 | 363.4 K to 385.4 K (+6.05 %) |
| Feb 15 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | M | 10.29 | 20,000 | 205,800 | 21,996 | |
| Feb 15 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | M | 10.29 | 20,000 | 205,800 | 41,996 | |
| Feb 15 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 84.95 | 20,000 | 1,699,000 | 363,388 | 383.4 K to 363.4 K (-5.22 %) |
| Feb 15 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 10.29 | 20,000 | 205,800 | 383,388 | 363.4 K to 383.4 K (+5.50 %) |
| Feb 15 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 84.34 | 20,000 | 1,686,800 | 363,388 | 383.4 K to 363.4 K (-5.22 %) |
| Feb 15 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 10.29 | 20,000 | 205,800 | 383,388 | 363.4 K to 383.4 K (+5.50 %) |
| Feb 06 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | M | 78.88 | 86,500 | 6,823,120 | 86,500 | |
| Feb 06 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 0.00 | 11,000 | 0 | 363,388 | 352.4 K to 363.4 K (+3.12 %) |
| Jan 30 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 74.51 | 3,480 | 259,295 | 352,388 | 355.9 K to 352.4 K (-0.98 %) |
| Jan 30 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 74.41 | 863 | 64,216 | 355,868 | 356.7 K to 355.9 K (-0.24 %) |
| Jan 11 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | M | 17.65 | 5,664 | 99,970 | 0 | |
| Jan 11 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | M | 5.18 | 20,000 | 103,600 | 20,000 | |
| Jan 11 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 75.00 | 1,036 | 77,700 | 356,731 | 357.8 K to 356.7 K (-0.29 %) |
| Jan 11 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 75.55 | 20,000 | 1,511,000 | 357,767 | 377.8 K to 357.8 K (-5.29 %) |
| Jan 11 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 17.65 | 5,664 | 99,970 | 377,767 | 372.1 K to 377.8 K (+1.52 %) |
| Jan 11 2012 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 5.18 | 20,000 | 103,600 | 372,103 | 352.1 K to 372.1 K (+5.68 %) |
| Jul 27 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | M | 5.18 | 20,000 | 103,600 | 20,000 | |
| Jul 27 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | M | 6.90 | 5,434 | 37,495 | 0 | |
| Jul 27 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 57.27 | 871 | 49,882 | 352,103 | 353 K to 352.1 K (-0.25 %) |
| Jul 27 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 58.27 | 19,934 | 1,161,554 | 352,974 | 372.9 K to 353 K (-5.35 %) |
| Jul 27 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 58.72 | 5,500 | 322,960 | 372,908 | 378.4 K to 372.9 K (-1.45 %) |
| Jul 27 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 5.18 | 20,000 | 103,600 | 378,408 | 358.4 K to 378.4 K (+5.58 %) |
| Jul 27 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 6.90 | 5,434 | 37,495 | 358,408 | 353 K to 358.4 K (+1.54 %) |
| Jul 15 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | M | 6.90 | 14,566 | 100,505 | 5,434 | |
| Jul 15 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 52.53 | 14,566 | 765,152 | 352,974 | 367.5 K to 353 K (-3.96 %) |
| Jul 15 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 6.90 | 14,566 | 100,505 | 367,540 | 353 K to 367.5 K (+4.13 %) |
| Jul 12 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 50.00 | 977 | 48,850 | 352,974 | 354 K to 353 K (-0.28 %) |
| Jun 01 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | M | 11.92 | 4,504 | 53,688 | 67,496 | |
| Jun 01 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Grant | A | 11.92 | 4,504 | 53,688 | 177,464 | 173 K to 177.5 K (+2.60 %) |
| Feb 16 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | S | 20.58 | 5,002 | 102,941 | 30,998 | |
| Feb 16 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 90.00 | 20,000 | 1,800,000 | 86,480 | 106.5 K to 86.5 K (-18.78 %) |
| Feb 16 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 20.58 | 5,002 | 102,941 | 106,480 | 101.5 K to 106.5 K (+4.93 %) |
| Feb 16 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 13.79 | 20,000 | 275,800 | 101,478 | 81.5 K to 101.5 K (+24.55 %) |
| Feb 04 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP, CFO | Option Exercise | A | 85.31 | 50,000 | 4,265,500 | 50,000 | |
| Feb 04 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP, CFO | Grant | A | 0.00 | 7,000 | 0 | 81,478 | 74.5 K to 81.5 K (+9.40 %) |
| Jan 28 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 84.70 | 1,731 | 146,616 | 74,478 | 76.2 K to 74.5 K (-2.27 %) |
| Jan 18 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 82.66 | 540 | 44,636 | 76,209 | 76.7 K to 76.2 K (-0.70 %) |
| Jan 12 2011 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 81.27 | 532 | 43,236 | 76,749 | 77.3 K to 76.7 K (-0.69 %) |
| Nov 23 2010 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | S | 16.35 | 4,000 | 65,400 | 0 | |
| Nov 23 2010 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | S | 13.79 | 20,000 | 275,800 | 40,000 | |
| Nov 23 2010 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 16.35 | 4,000 | 65,400 | 77,281 | 73.3 K to 77.3 K (+5.46 %) |
| Nov 23 2010 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 75.00 | 20,000 | 1,500,000 | 73,281 | 93.3 K to 73.3 K (-21.44 %) |
| Nov 23 2010 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 13.79 | 20,000 | 275,800 | 93,281 | 73.3 K to 93.3 K (+27.29 %) |
| Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | S | 16.35 | 4,000 | 65,400 | 4,000 | |
| Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Option Exercise | S | 13.79 | 20,000 | 275,800 | 60,000 | |
| Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 16.35 | 4,000 | 65,400 | 73,281 | 69.3 K to 73.3 K (+5.77 %) |
| Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Sell | S | 70.00 | 20,000 | 1,400,000 | 69,281 | 89.3 K to 69.3 K (-22.40 %) |
| Nov 05 2010 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | SVP & CFO | Buy | M | 13.79 | 20,000 | 275,800 | 89,281 | 69.3 K to 89.3 K (+28.87 %) |